Log in

RadNet Stock Price, Forecast & Analysis (NASDAQ:RDNT)

$16.14
+0.06 (+0.37 %)
(As of 11/12/2019 02:47 AM ET)
Today's Range
$15.92
Now: $16.14
$16.32
50-Day Range
$13.65
MA: $14.97
$16.34
52-Week Range
$9.97
Now: $16.14
$16.66
Volume104,755 shs
Average Volume236,305 shs
Market Capitalization$809.05 million
P/E Ratio24.45
Dividend YieldN/A
Beta0.86
RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. Read More…

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:RDNT
CUSIPN/A
Phone310-478-7808

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$975.15 million
Cash Flow$2.26 per share
Book Value$4.10 per share

Profitability

Net Income$32.24 million

Miscellaneous

Employees7,869
Market Cap$809.05 million
Next Earnings Date11/12/2019 (Confirmed)
OptionableOptionable

Receive RDNT News and Ratings via Email

Sign-up to receive the latest news and ratings for RDNT and its competitors with MarketBeat's FREE daily newsletter.


RadNet (NASDAQ:RDNT) Frequently Asked Questions

What is RadNet's stock symbol?

RadNet trades on the NASDAQ under the ticker symbol "RDNT."

How were RadNet's earnings last quarter?

RadNet Inc. (NASDAQ:RDNT) released its quarterly earnings results on Thursday, August, 8th. The medical research company reported $0.10 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.12 by $0.02. The medical research company had revenue of $289.10 million for the quarter, compared to analysts' expectations of $272.36 million. RadNet had a return on equity of 18.91% and a net margin of 3.33%. The company's quarterly revenue was up 18.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.11 EPS. View RadNet's Earnings History.

When is RadNet's next earnings date?

RadNet is scheduled to release their next quarterly earnings announcement on Tuesday, November 12th 2019. View Earnings Estimates for RadNet.

What price target have analysts set for RDNT?

1 Wall Street analysts have issued 12 month price objectives for RadNet's shares. Their forecasts range from $17.50 to $17.50. On average, they anticipate RadNet's stock price to reach $17.50 in the next twelve months. This suggests a possible upside of 8.4% from the stock's current price. View Analyst Price Targets for RadNet.

What is the consensus analysts' recommendation for RadNet?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RadNet in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for RadNet.

Has RadNet been receiving favorable news coverage?

News stories about RDNT stock have been trending very negative on Tuesday, according to InfoTrie. The research group identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. RadNet earned a news impact score of -3.2 on InfoTrie's scale. They also assigned news stories about the medical research company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the next few days. View News Stories for RadNet.

Who are some of RadNet's key competitors?

What other stocks do shareholders of RadNet own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RadNet investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Alibaba Group (BABA), UnitedHealth Group (UNH), Johnson & Johnson (JNJ), Adobe (ADBE), Cisco Systems (CSCO), Rigel Pharmaceuticals (RIGL), Baidu (BIDU) and Costco Wholesale (COST).

Who are RadNet's key executives?

RadNet's management team includes the folowing people:
  • Dr. Howard G. Berger, Chairman, Pres, CEO & Treasurer (Age 73)
  • Mr. Mark D. Stolper, Exec. VP & CFO (Age 48)
  • Mr. Norman R. Hames, Pres, COO of Western Operations & Director (Age 63)
  • Mr. Stephen M. Forthuber, Pres & COO of Eastern Operations (Age 58)
  • Mr. Ranjan Jayanathan, Chief Information Officer & GM of Radiology Information Technology Division

Who are RadNet's major shareholders?

RadNet's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Dalton Greiner Hartman Maher & Co. (2.48%), Beck Mack & Oliver LLC (2.13%), Russell Investments Group Ltd. (1.62%), Tamarack Advisers LP (0.65%), Cadence Capital Management LLC (0.47%) and Mackay Shields LLC (0.29%). Company insiders that own RadNet stock include David L Swartz, Jeffrey L Linden, John V Crues, Mark Stolper, Marvin S Cadwell, Michael L Md Sherman, Michael N Murdock and Norman R Hames. View Institutional Ownership Trends for RadNet.

Which institutional investors are selling RadNet stock?

RDNT stock was sold by a variety of institutional investors in the last quarter, including Miracle Mile Advisors LLC, Wedge Capital Management L L P NC, Strs Ohio, Cadence Capital Management LLC and First Allied Advisory Services Inc.. Company insiders that have sold RadNet company stock in the last year include David L Swartz, John V Crues, Mark Stolper, Michael L Md Sherman, Michael N Murdock and Norman R Hames. View Insider Buying and Selling for RadNet.

Which institutional investors are buying RadNet stock?

RDNT stock was acquired by a variety of institutional investors in the last quarter, including Tamarack Advisers LP, Russell Investments Group Ltd., Mackay Shields LLC, Assenagon Asset Management S.A., Essex Investment Management Co. LLC, Dalton Greiner Hartman Maher & Co., California Public Employees Retirement System and Monarch Partners Asset Management LLC. View Insider Buying and Selling for RadNet.

How do I buy shares of RadNet?

Shares of RDNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is RadNet's stock price today?

One share of RDNT stock can currently be purchased for approximately $16.14.

How big of a company is RadNet?

RadNet has a market capitalization of $809.05 million and generates $975.15 million in revenue each year. The medical research company earns $32.24 million in net income (profit) each year or $0.66 on an earnings per share basis. RadNet employs 7,869 workers across the globe.View Additional Information About RadNet.

What is RadNet's official website?

The official website for RadNet is http://www.radnet.com/.

How can I contact RadNet?

RadNet's mailing address is 1510 COTNER AVE, LOS ANGELES CA, 90025. The medical research company can be reached via phone at 310-478-7808 or via email at [email protected]


MarketBeat Community Rating for RadNet (NASDAQ RDNT)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  273 (Vote Outperform)
Underperform Votes:  257 (Vote Underperform)
Total Votes:  530
MarketBeat's community ratings are surveys of what our community members think about RadNet and other stocks. Vote "Outperform" if you believe RDNT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RDNT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/12/2019 by MarketBeat.com Staff

Featured Article: Cost of Goods Sold (COGS)

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel